Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: Positive modulation on natural killer activity

Obstetrics and Gynecology

Volumn 88, Issue 2, 1996, Pages 234-240

  Garzetti, G Gioele ^a,b   Ciavattini, Andrea ^a,b   Provinciali, Mauro ^a,b   Muzzioli, Mario ^a,b   Di Stefano, Giuseppina ^a,b   Fabris, Nicola ^a,b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Functional Genomics Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN; CD16 ANTIGEN; CD56 ANTIGEN; ESTRADIOL; GONADORELIN AGONIST; TRIPTORELIN;

ADJUVANT THERAPY; ADULT; ARTICLE; CELL STRAIN K 562; CLINICAL ARTICLE; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030221615     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00146-9     Document Type: Article

References (24)

1. 1. Guzick DS. Clinical epidemiology of endometriosis and infertility. Obstet Gynecol Clin North Am 1988;16:43-59.
2. 2. Rock JA, Moutos DM. Endometriosis: The present and the future - An overview of treatment opinion. Br J Obstet Gynaecol 1992;99(suppl. 7):1-4.
3. 3. Barbieri RL. Etiology and epidemiology of endometriosis. Am J Obstet Gynecol 1990;162:565-7.
4. 4. Shaw RW. The role of GnRH analogues in the treatment of endometriosis. Br J Obstet Gynaecol 1992;99(suppl. 7):9-12.
5. 5. Henzl MR, Corson SL, Moghissi K, Buttram VC, Berggvist C, Jacobson C. Administration of nasal nafarelin as compared with oral danazol for endometriosis. N Engl J Med 1988;318:455-89.
6. 6. Damario MA, Rock JA. Goserelin (Zoladex) versus danazol for endometriosis: The North American experience. Br J Obstet Gynaecol 1994;101(suppl. 10):13-8.
7. 7. Dmowski WP, Gebel HM, Braun DP. The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand 1994;159S:7-14.
8. 8. Gleicher N. The role of humoral immunity in endometriosis. Acta Obstet Gynecol Scand 1994;159S:15-7.
9. 9. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981;141:377-83.
10. 10. Gleicher N. Immune dysfunction - A potential target for treatment in endometriosis. Br J Obstet Gynaecol 1995;102(suppl. 12):4-7.
11. 11. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometriurn. Fertil Steril 1991;56:45-51.
12. 12. Garzetti GG, Ciavattini A, Provinciali M, Fabris N, Cignitti M, Romanini C. Natural killer cell activity in endometriosis: Correlation between serum estradiol levels and cytotoxicity. Obstet Gynecol 1993;81:665-8.
13. 13. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351-2.
14. 14. Provinciali M, Di Stefano G. Optimization of cytotoxic assay by target cell retention of the fluorescein diacetate (CFDA) and comparison with conventional 51CR release assay. J Immunol Methods 1992;155:19-22.
15. 15. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR, Vandeputte M. Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol 1993;82:206-12.
16. 16. Tanaka E, Sendo F, Kawagoe S, Hiroi M. Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 1992;34:27-30.
17. 17. Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano G, Fabris N. Natural killer activity in stage III and IV endometriosis: Impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells. Gynecol Endocrinol 1995;9:125-30.
18. 18. Seaman WE, Blackman MA, Gindhart TD, Roubinian JR, Loeb JM, Talal N. Beta-estradiol reduces natural killer cells in mice. J Immunol 1978;121:2193-8.
19. 19. Sulke AN, Jones DB, Wood PJ. Hormonal modulation of human natural killer cell activity in vitro. J Reprod Immunol 1985;7:105-10.
20. 20. Siiteri PK, Stites DP. Immunological and endocrine relationships in pregnancy. Biol Reprod 1982;26:1-14.
21. 21. Murphy AA, Green WR, Bobbie D, de la Cruz ZC, Rock JA. Unsuspected endometriosis documented by scanning electron microscopy in visually normal peritoneum. Fertil Steril 1986;46: 522-4.
22. 22. Redwine DB. Is "microscopic" peritoneal endometriosis invisible? Fertil Steril 1988;50:665-6.
23. 23. Thomas EJ. Combining medical and surgical treatment for endometriosis: The best of both worlds. Br J Obstet Gynaecol 1992; 99(suppl. 7):5-8.
24. 24. Brosens IA, Verleyen A, Cornillie F. The morphologic effect of short term medical therapy of endometriosis. Am J Obstet Gynecol 1987;157:1215-21.